CMV Infection in Pediatric Liver Transplantation and Comparison of Prophylaxis Methods Depending on Donor Serostatus
Cytomegalovirus viremia and disease are common in pediatric liver transplant recipients, with younger age being a signifi cant risk factor for CMV disease. However, CMV viremia and disease did not significantly impact this cohort's graft loss, acute cellular rejection, or mortality. The choice of antiviral treatment and immunosuppression protocols did not influence CMV outcomes. These find ings highlight the need for vigilant monitoring and tailored management strategies for CMV in pediatric liver transplantation. Cite this article as: Barut D, Kunay B, Yıldırım Arslan S, et al. CMV infection in pediatric liver transplantation and comparison of prophylaxis methods depending on donor serostatus. Turk J Gastroenterol. 2026;37(2):242-250.
Authors
- Doğan Barut (ORCID: https://orcid.org/0000-0002-4662-4252)
- Ezgi Kıran Taşçı (ORCID: https://orcid.org/0000-0001-5842-0292)
- Miray Karakoyun (ORCID: https://orcid.org/0000-0002-6533-6256)
- Veysel Umman
- Bora Kunay (ORCID: https://orcid.org/0000-0002-9577-5815)
- Funda Özgenç (ORCID: https://orcid.org/0000-0002-7394-1392)
- Zümrüt Şahbudak Bal (ORCID: https://orcid.org/0000-0001-9189-8220)
- Gözde Akkuş Kayalı (ORCID: https://orcid.org/0000-0002-5776-4277)
- Aydogdu Sema (ORCID: https://orcid.org/0000-0001-6479-7301)
- Dernek Benan (ORCID: https://orcid.org/0009-0005-3147-2638)
- Sema Yıldırım Arslan (ORCID: https://orcid.org/0000-0003-2240-4092)
Institutions
- Izmir University (TR)
- Ege University (TR)
- Sivas State Hospital (TR)
Publication Details
- Journal
- The Turkish Journal of Gastroenterology
- Published
- 2025-11-07
- DOI
- https://doi.org/10.5152/tjg.2025.24585
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00